Grant: P008256001 & P008256002: CanExport - Innovation
iProgen Biotech Inc.
$7,205.00
P008256001: CXI - iProgen Biotech Inc. 2019-2020 P008256002: CXI - iProgen Biotech Inc. 2019-2020
EF 2019-20 · 2019-09-25
Résumé
P008256001: The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
P008256002: The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
Ministère
Programme
P008256001 & P008256002: CanExport - Innovation
Bénéficiaire
Emplacement
Burnaby | Burnaby, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
826908816
Type
Grant
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2020-03-31
Agreement Number
7411895 P008256001 P008256002
Agreement Start Date
2019-09-25
Agreement Title
P008256001: CXI - iProgen Biotech Inc. 2019-2020
P008256002: CXI - iProgen Biotech Inc. 2019-2020
Agreement Title (French)
P008256001: CXI - iProgen Biotech Inc. 2019-2020
P008256002: CXI - iProgen Biotech Inc. 2019-2020
Agreement Type
Grant
Agreement Value
$7,205.00
Amendment Number
0
Description
P008256001: The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
P008256002: The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
Description (French)
P008256001: L’objectif de cet accord de contribution en matière de la CanExport Innovation (CXI) accord de subvention consiste à appuyer les organisations et à s’appuyer sur des relations ciblées entre des entreprises/chercheurs canadiens et des organisations clés dans d’autres pays afin de permettre à ces derniers d’aller de l’avant avec des discussions officielles en vue d’établir des collaborations concernant des initiatives internationales futures en matière de R-D qui pourraient mener à la commercialisation de technologies canadiennes.
P008256002: L’objectif de cet accord de contribution en matière de la CanExport Innovation (CXI) accord de subvention consiste à appuyer les organisations et à s’appuyer sur des relations ciblées entre des entreprises/chercheurs canadiens et des organisations clés dans d’autres pays afin de permettre à ces derniers d’aller de l’avant avec des discussions officielles en vue d’établir des collaborations concernant des initiatives internationales futures en matière de R-D qui pourraient mener à la commercialisation de technologies canadiennes.
Expected Results
P008256001: Increase Canadian science and technological innovation and commercialization opportunities as measured by analysis of recipient performance reports and surveys.
P008256002: Increase Canadian science and technological innovation and commercialization opportunities as measured by analysis of recipient performance reports and surveys.
Expected Results (French)
P008256001: Accroître les possibilités d’innovation et de commercialisation de la science et de la technologie canadiennes; ce résultat est évalué par l’analyse des rapports et des sondages sur le rendement des bénéficiaires.
P008256002: Accroître les possibilités d’innovation et de commercialisation de la science et de la technologie canadiennes; ce résultat est évalué par l’analyse des rapports et des sondages sur le rendement des bénéficiaires.
Federal Riding
Burnaby North--Seymour
Federal Riding (French)
Burnaby-Nord--Seymour
Federal Riding Number
59002
Organization Code
dfatd-maecd
Organization
Global Affairs Canada | Affaires mondiales Canada
Program Name
P008256001 & P008256002: CanExport - Innovation
Program Name (French)
P008256001 & P008256002 : CanExport - Innovation
Program Purpose
P008256001 & P008256002: Promote and enhance Canada’s international innovation efforts by supporting innovators (employees of academic institutions, Canadian companies and non-government research centres that are seeking to commercialize technology) pursue international Research and Development (R&D) collaborative opportunities through the development of partnerships with key players in other countries/economies.
Program Purpose (French)
P008256001 & P008256002 : Promouvoir et d’accroître les efforts du Canada en matière d’innovation à l’échelle internationale en aidant les innovateurs (employés d’établissements d’enseignement, d’entreprises canadiennes et de centres de recherche non gouvernementaux qui cherchent à commercialiser la technologie) à trouver des possibilités de collaboration en R-D à l’étranger à l’aide de la formation de partenariats avec des partenaires clés dans d’autres pays ou économies.
Recipient Business Number
826908816
Recipient City
Burnaby | Burnaby
Recipient Country
CA
Recipient Legal Name
iProgen Biotech Inc.
Recipient Postal Code
V5A 4N4
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
064-2019-2020-Q2-00173